Drug Pricing Concerns Shape Policy Decisions in 2003

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2003, Volume 27, Issue 12

FDA initiatives aim to spur the development of more-affordable treatments and ensure safe product use.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-12-02-2003
FDA Reports on Status of Postmarketing Requirements and Postmarketing Commitments
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients
Navigating an Uncertain Regulatory Environment for mRNA-based Products